Form 4: Encompass Health Director Terrance Williams Reports Acquisition of 1,978 Shares

Sentiment:

SEC Form 4 Filing


Director Terrance Williams reports acquiring 1,978 shares of Encompass Health Corp stock through an annual grant of restricted stock units.

Summary

  • Terrance Williams, a director of Encompass Health Corp, filed a Form 4 with the SEC.
  • The filing reports that on May 2, 2024, Williams acquired 1,978 shares of Encompass Health common stock.
  • This acquisition was an annual grant of restricted stock units (RSUs) under the company's 2016 Omnibus Performance Incentive Plan.
  • The price per share was $0.
  • Following the transaction, Williams directly owns 13,574 shares of Encompass Health common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a routine disclosure of stock acquisition by a director as part of a compensation plan. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard corporate governance practices.

Positives

  • The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it is a routine grant of restricted stock units to a director.

Key Dates

DateDescription
05/02/2024Date of transaction: Acquisition of 1,978 shares of Encompass Health common stock.
05/03/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.